Table 2.
Demographic Characteristics of the participants and SARS-CoV-2 vaccination.
| Variables |
Vaccinated N:51,320 (78.6%) |
Unvaccinated N:13,950(21.4%) |
P value** |
|---|---|---|---|
| Age Groups, years | <0.0001 | ||
| <25 | 2314(65.3%) | 1228(34.7%) | |
| 25–34 | 13,230(72.5%) | 5022(27.5%) | |
| 35–44 | 13,188(78.3%) | 3648(21.7%) | |
| 45–54 | 10,224(82.2%) | 2215(17.8%) | |
| 55–65 | 9949(86.2%) | 1590(13.8%) | |
| >=65 | 2412(90.7%) | 246(9.3%) | |
| Gender | <0.0001 | ||
| Male | 15,516(81.9%) | 3433(18.12%) | |
| Female | 35,796(77.3%) | 10,509(22.7%) | |
| Race/Ethnicity | <0.0001 | ||
| Non-Hispanic White | 41,230(80.3%) | 10,125(19.7%) | |
| Black | 1575(61.5%) | 988(38.5%) | |
| Hispanic | 2153(75.3%) | 706(24.7%) | |
| Asian | 3824(87.9%) | 524(12.1%) | |
| Other | 928(73.3%) | 338(26.7%) | |
| Job location | <0.0001 | ||
| Midwest region | 39,040(81.1%) | 9111(18.9%) | |
| Arizona | 6471(74.2%) | 2246(25.8%) | |
| Florida | 5590 (70.3%) | 2364(29.7%) | |
| Job category | <0.0001 | ||
| Administrative Staff | 5735(82.5%) | 1216(17.5%) | |
| Physician | 6351(95.8%) | 277(4.2%) | |
| Advanced Practice | 3858(89%) | 477(11%) | |
| Nurse | 12,644(78.9%) | 3386(21.1%) | |
| Healthcare Professional | 3111(83.6%) | 611(16.4%) | |
| Clinical Support Staff | 4351(70.6%) | 1815(29.4%) | |
| Research | 4438(75.3%) | 1454(24.7%) | |
| Student Worker | 1097(82.5%) | 232(17.5%) | |
| Nonclinical Support Staff | 9,038(68.9%) | 4,074(31.1%) | |
| Patient Care Role | <0.0001 | ||
| Direct Care | 29,970(82.4%) | 6,414 (17.6%) | |
| No Direct Care | 20,653(74.3%) | 7,128(25.7%) | |
| Duration of hire, months Median (IQR) | 80.8(0-775.5) | 46.5(0-626.8) | <0.0001 |
| Prior positive SARS-CoV-2 molecular assay*** | 3,018(68.8%) | 1,368(31.2%) | <0.0001 |
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
*Missing variables for age, gender, race, patient care, job category and location were excluded from the analysis.
** Nonparametric Wilcoxon rank-sum test for continuous variables and the chi-square test for categorical variables.
***Includes positive tests prior to vaccine availability on 12/18/2020 for both groups.